From Prognosis to Practice: How Should We Use ctDNA-Guided MRD Testing in Colorectal Cancer Today?

Wednesday, January 27, 2027 at 5:30 PM to 6:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
CancerDiagnosticsLiquid Biopsy

Information

This session will explore: 

  • What ctDNA-guided MRD testing can reliably tell us today 
  • Key differences between Stage II and Stage III colorectal cancer 
  • Current evidence from DYNAMIC, GALAXY, TRACC and other major studies